Exfoliative dermatitis - Dermatite Esfoljattiva
☆ Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
Red (burning) Skin Syndrome ― Eritema u skala fuq il-ġisem kollu huma s-sintomi ewlenin ta' Dermatite Esfoljattiva (Exfoliative dermatitis).
References
Erythroderma hija kundizzjoni tal-ġilda rari iżda serja. Filwaqt li l-kawża eżatta ħafna drabi mhix magħrufa, tista 'tiġi attivata minn reazzjoni għal mediċina jew kanċer sottostanti. Kanċer wieħed komuni marbut mad-dermatite esfoljattiva hija l-limfoma taċ-ċelluli T tal-ġilda, li tista’ ma turix sintomi għal xhur jew saħansitra snin wara li tibda l-kundizzjoni tal-ġilda. Normalment, l-isptar hija meħtieġa għall-valutazzjoni u t-trattament inizjali. Pazjenti b'mard ikkawżat mid-droga ġeneralment ikollhom prospetti tajba fit-tul, għalkemm każijiet mingħajr kawża ċara għandhom it-tendenza li jkollhom kors rikorrenti u remittenti. Il-pronjosi għal każijiet marbuta mal-kanċer tipikament tiddependi fuq kif il-kanċer jimxi 'l quddiem.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Tipikament juri ħmura mifruxa u tqattigħ li jkopri aktar minn 90% tal-ġisem. Din il-kundizzjoni hija sinjal viżibbli ta 'diversi kwistjonijiet ta' saħħa sottostanti bħal psorjasi, ekżema, jew rispons għal ċerti mediċini.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
L-aktar kawża komuni ta 'eritroderma hija aggravament ta' marda tal-ġilda sottostanti, bħal psorjasi, dermatite tal-kuntatt, dermatite seborrheic, lichen planus, pityriasis rubra pilaris jew reazzjoni ta 'mediċina, bħall-użu ta' sterojdi topiċi. Il-manefestazzjoni primarja hija inqas frekwenti u ġeneralment tidher f'każijiet ta' limfoma taċ-ċelluli T tal-ġilda. Minħabba li huwa importanti li tiġi differenzjata mil-limfoma taċ-ċelluli T tal-ġilda, issir bijopsija.